Molecular characterization of hepatitis C virus for subtype determination and resistance-associated substitutions detection among Chinese voluntary blood donors

被引:3
作者
Jiang, Xinyi [1 ,2 ,3 ]
Lv, Xiaoting [4 ]
Chang, Le [1 ,2 ]
Yan, Ying [1 ,2 ]
Ji, Huimin [1 ,2 ]
Sun, Huizhen [1 ,2 ,3 ]
Guo, Fei [1 ,2 ]
Rodgers, Mary A. [5 ]
Yin, Peng [5 ]
Wang, Lunan [1 ,2 ,3 ]
机构
[1] Chinese Acad Med Sci, Beijing Hosp, Inst Geriatr Med, Natl Ctr Clin Labs,Natl Ctr Gerontol, Beijing, Peoples R China
[2] Beijing Hosp, Beijing Engn Res Ctr Lab Med, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Grad Sch, Peking Union Med Coll, Beijing, Peoples R China
[4] Abbott Labs, Res & Dev, Shanghai, Peoples R China
[5] Abbott Labs, Infect Dis Res, Abbott Pk, IL 60064 USA
关键词
Hepatitis C Virus; Molecular characterization; Resistance-associated substitutions; NS3 and NS5A inhibitors; Blood donors; TREATMENT-NAIVE PATIENTS; ACTING ANTIVIRAL DRUGS; GENOTYPE; IN-VITRO; NS5A INHIBITOR; COMBINATION THERAPY; HCV NS5A; NS3; DACLATASVIR; INFECTION;
D O I
10.1016/j.antiviral.2020.104871
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The high prevalence of hepatitis C virus (HCV) infection and the resulting burden of the disease are significant issues to public health worldwide. Although direct-acting antiviral drugs (DAAs) with good tolerance and bioavailability are available, resistance-associated substitutions (RASs) often jeopardize the successful sustainment of virological responses in HCV treatment. High-frequency baseline RASs in treatment-naive patients can lead to failures in DAA treatment. Clinical data on HCV RASs in patients from China are limited and require investigations. Methods: 262 HCV RNA positive plasma from Chinese blood donors were genotyped and amplified with subtype-specific primers for NS3 and NS5A regions. RASs were analyzed using Geno2pheno. The codon usage of each resistance-associated substitution was calculated for genetic barrier analysis. Results: The two main subtypes in mainland China were 1b and 2a, followed by subtype 6a, 3b, 3a, and 1a. In NS3 region of 1b subtype, substitutions (T54S, V55A, Y56F, Q80 K/L, S122 G/T, R117 H/C, V170I and S174A) were present in 89.7% (96/107) of the samples. Other RASs (M28L, R30Q, P58 L/S and Y93H) were observed in 22.1% (25/113) of the samples in NS5A region. A crucial RAS, Q80K, and two other mutations (S122G thorn V170I) was identified in the same sequence, which reduced its susceptibility to protease inhibitor ASV and resulted in resistance to SMV. In NS5A, Y93H was detected in 9.7% (11/113) of the 1b samples, leading to medium-to-high level resistance to all six commercialized NS5A inhibitors. S122G-NS3 and Y93H-NS5A occurred simultaneously in 38.1% (7/22) of the samples with mutations in both two regions. Moreover, codon usage of S122G-NS3 and Y93H-NS5A revealed that both variants had the lowest genetic barrier and required only one transition to confer resistance. Conclusions: Low genetic barriers facilitated the generation of resistance mutants and
引用
收藏
页数:9
相关论文
共 75 条
[1]   Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection [J].
Ghany M.G. ;
Morgan T.R. .
HEPATOLOGY, 2020, 71 (02) :686-721
[2]  
[Anonymous], 2013, CHEMMEDCHEM, DOI DOI 10.1371/JOURNAL.PONE.0072467
[3]  
[Anonymous], 2015, J INFECT DIS, DOI DOI 10.1016/J.AJOG.2015.06.062
[4]  
[Anonymous], 2017, AASLD
[5]   Susceptibility of Treatment-Naive Hepatitis C Virus (HCV) Clinical Isolates to HCV Protease Inhibitors [J].
Bae, Andrew ;
Sun, Siu-Chi ;
Qi, Xiaoping ;
Chen, Xiaowu ;
Ku, Karin ;
Worth, Angela ;
Wong, Kelly A. ;
Harris, Jeanette ;
Miller, Michael D. ;
Mo, Hongmei .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (12) :5288-5297
[6]   Analysis of boceprevir resistance associated amino acid variants (RAVs) in two phase 3 boceprevir clinical studies [J].
Barnard, Richard J. O. ;
Howe, John A. ;
Ogert, Robert A. ;
Zeuzem, Stefan ;
Poordad, Fred ;
Gordon, Stuart C. ;
Ralston, Robert ;
Tong, Xiao ;
Sniukiene, Vilma ;
Strizki, Julie ;
Ryan, Desmond ;
Long, Jianmin ;
Qiu, Ping ;
Brass, Clifford A. ;
Albrecht, Janice ;
Burroughs, Margaret ;
Vuocolo, Scott ;
Hazuda, Daria J. .
VIROLOGY, 2013, 444 (1-2) :329-336
[7]   The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection [J].
Bartenschlager, Ralf ;
Lohmann, Volker ;
Penin, Francois .
NATURE REVIEWS MICROBIOLOGY, 2013, 11 (07) :482-496
[8]   Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study [J].
Blach, Sarah ;
Zeuzem, Stefan ;
Manns, Michael ;
Altraif, Ibrahim ;
Duberg, Ann-Sofi ;
Muljono, David H. ;
Waked, Imam ;
Alavian, Seyed M. ;
Lee, Mei-Hsuan ;
Negro, Francesco ;
Abaalkhail, Faisal ;
Abdou, Ahmed ;
Abdulla, Maheeba ;
Abou Rached, Antoine ;
Aho, Inka ;
Akarca, Ulus ;
Al Ghazzawi, Imad ;
Al Kaabi, Saad ;
Al Lawati, Faryal ;
Al Namaani, Khalid ;
Al Serkal, Youssif ;
Al-Busafi, Said A. ;
Al-Dabal, Layla ;
Aleman, Soo ;
Alghamdi, Abdullah S. ;
Aljumah, Abdulrahman A. ;
Al-Romaihi, Hamad E. ;
Andersson, Monique I. ;
Arendt, Vic ;
Arkkila, Perttu ;
Assiri, Abdullah M. ;
Baatarkhuu, Oidov ;
Bane, Abate ;
Ben-Ari, Ziv ;
Bergin, Colm ;
Bessone, Fernando ;
Bihl, Florian ;
Bizri, Abdul R. ;
Blachier, Martin ;
Blasco, Antonio J. ;
Mello, Carlos E. Brandao ;
Bruggmann, Philip ;
Brunton, Cheryl R. ;
Calinas, Filipe ;
Chan, Henry L. Y. ;
Chaudhry, Asad ;
Cheinquer, Hugo ;
Chen, Chien-Jen ;
Chien, Rong-Nan ;
Choi, Moon Seok .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (03) :161-176
[9]   HCV Genotypes Are Differently Prone to the Development of Resistance to Linear and Macrocyclic Protease Inhibitors [J].
Cento, Valeria ;
Mirabelli, Carmen ;
Salpini, Romina ;
Dimonte, Salvatore ;
Artese, Anna ;
Costa, Giosue ;
Mercurio, Fabio ;
Svicher, Valentina ;
Parrotta, Lucia ;
Bertoli, Ada ;
Ciotti, Marco ;
Di Paolo, Daniele ;
Sarrecchia, Cesare ;
Andreoni, Massimo ;
Alcaro, Stefano ;
Angelico, Mario ;
Perno, Carlo Federico ;
Ceccherini-Silberstein, Francesca .
PLOS ONE, 2012, 7 (07)
[10]   Demographic characteristics of transfusion-transmitted infections among blood donors in China [J].
Chang, Le ;
Zhao, Junpeng ;
Guo, Fei ;
Ji, Huimin ;
Zhang, Lu ;
Jiang, Xinyi ;
Wang, Lunan .
BMC INFECTIOUS DISEASES, 2019, 19 (1)